–
Closing
–
1D
–
YTD
Market cap
-
52 week high
-
52 week low
-
Volume
-
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $3.99/month
Market cap
-
Analysts' Rating
-
Price Target (Mean)
-
Total Analysts
0
P/E
-
Operating Margin
-
Beta
-
Revenue Growth (Annual)
-66.77%
52 week high
-
52 week low
-
Div. Yield
-
EPS Annual Growth
-
Note on Purification and Zakat
- Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly).
- If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
- For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them.
Company Profile
Allegra Orthopaedics Limited is an Australia-based company engaged in the design and distribution of orthopedic products. The Company’s principal product, the Active Total Knee, is a primary total knee replacement prosthesis. The Company is also the exclusive distributor of Waldemar Link GmbH & Co. KG products in Australia. Its Link products consist of a range of complex lower limb, hip, and knee replacements, including oncology solutions. The Link products add to Allegra’s well-developed range of products for distribution from international suppliers covering all specialties from foot and ankle to the upper limb. The Company operates in two segments: the Orthopaedics division, and the Innovation division. The Company’s Orthopaedics Division is engaged in the sale and distribution of its medical device product portfolio. The Company’s Innovation Division invests resources in the development and commercialization of new products.
